Rosenfeld Eric H, Vogel Adam M, Klinkner Denise B, Escobar Mauricio, Gaines Barbara, Russell Robert, Campbell Brendan, Wills Hale, Stallion Anthony, Juang David, Thakkar Rajan K, Upperman Jeffrey, Jafri Mubeen, Burd Randall, Naik-Mathuria Bindi J
Texas Children's Hospital and the Michael E DeBakey, Department of Surgery, Houston, TX.
Saint Louis Children's Hospital, St. Louis, MO.
J Pediatr Surg. 2017 Oct 13. doi: 10.1016/j.jpedsurg.2017.10.038.
BACKGROUND/PURPOSE: Endoscopic retrograde cholangiopancreatography (ERCP) is an adjunct for pediatric pancreatic injury management, but its use and utility in pediatric patients are unclear. We set out to evaluate the use of ERCP and its effects on outcomes.
A retrospective review was performed for children who had pancreatic injuries at 22 pediatric trauma centers between 2010 and 2015. ERCP details and outcomes were collected. Analysis was performed using descriptive statistics and Wilcoxon rank-sum tests.
ERCP was used at 14/22 centers for 26 patients. Indications were duct evaluation, duct leak control, pseudocyst, fistula, and stricture. ERCP altered management or improved outcomes in 13/26 (50%), most commonly in patients with ERCP for duct evaluation, stricture, and fistula. In patients managed nonoperatively, those with early endoscopic intervention (within one week of injury) with stent or sphincterotomy (n=9) had similar time to regular diet [median (IQR)]: [10 (7-211) vs 7 (4-12) days; p=0.55], similar hospital days: [12 (8-20) vs 11 (6-19) days, p=0.63], and similar time on parenteral nutrition: [17 (10-40) vs 10 (6-18) days; p=0.19] compared to patients who were only observed.
In children with blunt pancreatic injury, ERCP can be useful to diagnose duct injury and for management of late complications such as stricture and fistula. However, early endoscopic intervention for pancreatic duct disruption may not improve outcome or expedite recovery. Further study is needed.
Retrospective Study; Treatment Study.
III.
背景/目的:内镜逆行胰胆管造影术(ERCP)是小儿胰腺损伤治疗的一种辅助手段,但其在小儿患者中的应用及效用尚不清楚。我们旨在评估ERCP的应用及其对治疗结果的影响。
对2010年至2015年间在22家小儿创伤中心发生胰腺损伤的儿童进行回顾性研究。收集ERCP的详细情况及治疗结果。采用描述性统计和Wilcoxon秩和检验进行分析。
22家中心中的14家对26例患者使用了ERCP。适应证包括导管评估、导管漏控制、假性囊肿、瘘管和狭窄。ERCP改变了治疗方案或改善了治疗结果的有13/26例(50%),最常见于因导管评估、狭窄和瘘管而行ERCP的患者。在非手术治疗的患者中,早期(受伤后1周内)接受支架置入或括约肌切开术的内镜干预患者(n = 9)与仅接受观察的患者相比,恢复正常饮食的时间[中位数(四分位间距)]相似:[10(7 - 211)天对7(4 - 12)天;p = 0.55],住院天数相似:[12(8 - 20)天对11(6 - 19)天,p = 0.63],肠外营养时间相似:[17(10 - 40)天对10(6 - 18)天;p = 0.19]。
在钝性胰腺损伤的儿童中,ERCP有助于诊断导管损伤及处理诸如狭窄和瘘管等晚期并发症。然而,早期内镜干预胰腺导管破裂可能无法改善治疗结果或加速康复。需要进一步研究。
回顾性研究;治疗研究。
III级。